111 Operating Margin 2018-2025 | YI
Current and historical operating margin for 111 (YI) over the last 10 years. The current operating profit margin for 111 as of March 31, 2025 is -0.48%.
| 111 Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $1.97B | $0.00B | -0.05% |
| 2024-12-31 | $1.97B | 0 | 0.00% |
| 2024-09-30 | $2.06B | $-0.03B | -1.36% |
| 2024-06-30 | $2.05B | $-0.04B | -1.91% |
| 2024-03-31 | $2.06B | $-0.05B | -2.19% |
| 2023-12-31 | $2.11B | $-0.05B | -2.33% |
| 2023-09-30 | $2.09B | $-0.03B | -1.63% |
| 2023-06-30 | $2.05B | $-0.03B | -1.66% |
| 2023-03-31 | $2.03B | $-0.04B | -1.97% |
| 2022-12-31 | $1.96B | $-0.05B | -2.71% |
| 2022-09-30 | $1.96B | $-0.06B | -2.91% |
| 2022-06-30 | $2.01B | $-0.07B | -3.64% |
| 2022-03-31 | $2.02B | $-0.09B | -4.45% |
| 2021-12-31 | $1.95B | $-0.10B | -5.13% |
| 2021-09-30 | $1.84B | $-0.11B | -5.82% |
| 2021-06-30 | $1.67B | $-0.10B | -5.87% |
| 2021-03-31 | $1.43B | $-0.08B | -5.73% |
| 2020-12-31 | $1.26B | $-0.07B | -5.72% |
| 2020-09-30 | $0.99B | $-0.07B | -7.14% |
| 2020-06-30 | $0.80B | $-0.07B | -8.74% |
| 2020-03-31 | $0.69B | $-0.07B | -10.39% |
| 2019-12-31 | $0.57B | $-0.07B | -12.68% |
| 2019-09-30 | $0.45B | $-0.07B | -14.99% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.057B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $44.935B | 57.17 |
| Tempus AI (TEM) | United States | $12.393B | 0.00 |
| Doximity (DOCS) | United States | $11.901B | 52.95 |
| Hims & Hers Health (HIMS) | United States | $10.549B | 87.28 |
| IRhythm Technologies (IRTC) | United States | $5.208B | 0.00 |
| Hinge Health (HNGE) | United States | $4.462B | 0.00 |
| Privia Health (PRVA) | United States | $2.542B | 188.27 |
| Inspire Medical Systems (INSP) | United States | $2.501B | 36.77 |
| Phreesia (PHR) | United States | $1.667B | 0.00 |
| Enovis (ENOV) | United States | $1.647B | 8.71 |
| 10x Genomics (TXG) | United States | $1.630B | 0.00 |
| Omnicell (OMCL) | United States | $1.446B | 27.85 |
| Schrodinger (SDGR) | United States | $1.427B | 0.00 |
| Azenta (AZTA) | United States | $1.402B | 61.18 |
| Clover Health Investments (CLOV) | United States | $1.317B | 0.00 |
| Claritev (CTEV) | United States | $1.117B | 0.00 |
| Evolent Health (EVH) | United States | $1.035B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.665B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.509B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Standard BioTools (LAB) | United States | $0.463B | 0.00 |
| Talkspace (TALK) | United States | $0.424B | 126.50 |
| Carlsmed (CARL) | $0.370B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.355B | 0.00 |
| TruBridge (TBRG) | United States | $0.287B | 50.40 |
| Nyxoah SA (NYXH) | Belgium | $0.232B | 0.00 |
| Outset Medical (OM) | United States | $0.229B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.222B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.190B | 0.00 |
| CapsoVision (CV) | United States | $0.186B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.134B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| CareCloud (CCLD) | United States | $0.108B | 4.92 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.093B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.069B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.019B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |